MARLBOROUGH, Mass.--(BUSINESS WIRE)--Optos plc (LSE: OPTS), a world leader in retinal imaging, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...

Please provide your email address to receive an email when new articles are posted on . An OCT integrated into an ultra-widefield device provides similar visualization of retinal structural details in ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Optos says deal for $17.5 mln Deal to close in Q4 Optos enters $30 mln credit pact Sept 22 (Reuters) - Scottish retinal-imaging equipment firm Optos offered to buy a unit of U.S.-based Opko Health Inc ...

A new laser-based imaging technology for early detection of a range of serious eye diseases is set for a clinical study in the UK. Dunfermline-based Optos, which is listed on the London Stock Exchange ...